June 01, 2006 23:59 ET

OPMEDIC GROUP announces it will vigorously defend against allegations made by Warnex Inc.

MONTREAL, June 1 - Not for dissemination in the United States.

a healthcare-related services company providing facilities and
services to patients and surgeons, announces that it was served yesterday,
May 31, 2006, with a motion for a temporary injunction. This proceeding was
initiated by Warnex Inc. to prevent OPMEDIC Group from proposing a prenatal
test through its PROCREA Cliniques division. According to Warnex Inc., this
test would compete with Warnex Inc. screening test, Prenatest®, purportedly
in violation with an agreement entered into with OPMEDIC Group.

OPMEDIC Group denies such allegations and believes that these proceedings
are unfounded. OPMEDIC Group intends to vigorously defend against the
allegations made by Warnex Inc. To that end, OPMEDIC Group will use all
available legal means to defend against any proceedings initiated in
connection with that matter.

The parties appeared today in the Superior Court, District of Montreal,
to present their arguments. The injunction application, as presented, was
rejected by the judge. However, the Court has issued an interim injunction
ordering OPMEDIC Group not to present doctors with any new advertising and
solicitation concerning the new test until June 9, 2006. Consequently, OPMEDIC
Group can currently keep on using the new test.


OPMEDIC GROUP is a company incorporated under the laws of the Province of
Quebec which provides healthcare-related services including surgical
facilities and services to patients and surgeons (with its OPMEDIC division),
fertility treatments, medical imaging, laboratory services and diagnostic
procedures (with its PROCREA Cliniques division) and sperm banking services
(with its PROCREA Cryopreservation Centre subsidiary). OPMEDIC GROUP's Common
Shares trade on the Toronto Stock Exchange under the symbol "OMG".

This news release does not constitute an offer to sell or to solicitation
of an offer to buy any security and shall not constitute an offer,
solicitation or sale in any jurisdiction in which such offerting would be
unlawful. This news release contains certain forward-looking statements that
reflect the current views and/or expectations of OPMEDIC GROUP with respect to
its performance, business and future events. Such statements are subject to a
number of risks, uncertainties and assumptions. Actual results and events may
vary significantly.

The Content of this press release has not been approved by nor submitted
to the TSX which assumes no liability therefore.

Contact Information